Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase NA 4Phase 3 4Phase 4 3Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Urologic Neoplasms 1Intracranial Aneurysm 1Hemangioma, Cavernous 1Breast Neoplasms 1Arteriovenous Malformations 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Doxycycline × Clear all
NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
18 enrolled
BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT00783523 2013-08-09

Influence of MMP on Brain AVM Hemorrhage

University of California, San Francisco

Phase 1 Completed
33 enrolled

Arteriovenous Malformations, Intracranial Aneurysm, Hemangioma, Cavernous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡